INTRODUCTION: The aim of this study was to determine incidence of cardiovascular disease (CVD) risk factors [hypertension (HTN), obesity, Dyslipidemia (DLP), diabetes mellitus (DM) and smoking] in Oskoo. METHODS: This study was planned according to WHO protocol "WHO CVD-risk management package for low and medium-resource settings" and named "East Azerbaijan healthy heart program". The pilot study of this program was done in Oskoo in 2007-2009. In this study, demographic data and CVD risk factors of 37,329 adults aged ≥30 years old living in Oskoo were collected. In addition, blood samples of 17,388 adults ≥40 years old were taken (free of charge) for assessment of serum glucose and lipid profile. RESULTS: The study covered 93.52% of Oskoo town population aged≥30 years old. We studied 18637 male (91.50% coverage) and 18692 female (95.52% coverage) participants. The incidence of HTN [SBP≥140 & DBP≥90 mmHg] was 16.25% (M:15.08%, F:17.29%), pre-hypertension [SBP=120-139 & DBP=80-89 mmHg] =37.78% (M:41.38%, F:34.18%), DM [fast blood glucose (FBS)≥126mg/dl] was 7.45% (M:6.35%, F:8.54%), smoking was 9.40% (M:17.00%, F:1.57%), hypercholesterolemia (>200mg/dl) was 47.64% (M:42.46%, F:52.81%) and obesity [body mass index (BMI) ≥27] was 50.47% (M:38.79%, F:62.09%). CONCLUSION: Considering high incidence of CVD risk factors (except smoking) in Oskoo adults ≥30 years, it is recommended that this pilot study expanded to all of East Azerbaijan. Free of charge taking blood samples from people ≥ 40 years to evaluate lipid profile and glucose levels is worthy to early detecting the prevalent DM or DLP in this target population.
INTRODUCTION: The aim of this study was to determine incidence of cardiovascular disease (CVD) risk factors [hypertension (HTN), obesity, Dyslipidemia (DLP), diabetes mellitus (DM) and smoking] in Oskoo. METHODS: This study was planned according to WHO protocol "WHO CVD-risk management package for low and medium-resource settings" and named "East Azerbaijan healthy heart program". The pilot study of this program was done in Oskoo in 2007-2009. In this study, demographic data and CVD risk factors of 37,329 adults aged ≥30 years old living in Oskoo were collected. In addition, blood samples of 17,388 adults ≥40 years old were taken (free of charge) for assessment of serum glucose and lipid profile. RESULTS: The study covered 93.52% of Oskoo town population aged≥30 years old. We studied 18637 male (91.50% coverage) and 18692 female (95.52% coverage) participants. The incidence of HTN [SBP≥140 & DBP≥90 mmHg] was 16.25% (M:15.08%, F:17.29%), pre-hypertension [SBP=120-139 & DBP=80-89 mmHg] =37.78% (M:41.38%, F:34.18%), DM [fast blood glucose (FBS)≥126mg/dl] was 7.45% (M:6.35%, F:8.54%), smoking was 9.40% (M:17.00%, F:1.57%), hypercholesterolemia (>200mg/dl) was 47.64% (M:42.46%, F:52.81%) and obesity [body mass index (BMI) ≥27] was 50.47% (M:38.79%, F:62.09%). CONCLUSION: Considering high incidence of CVD risk factors (except smoking) in Oskoo adults ≥30 years, it is recommended that this pilot study expanded to all of East Azerbaijan. Free of charge taking blood samples from people ≥ 40 years to evaluate lipid profile and glucose levels is worthy to early detecting the prevalent DM or DLP in this target population.
Authors: H Sadeghi-Bazargani; H Jafarzadeh; M Fallah; S Hekmat; J Bashiri; G h Hosseingolizadeh; M S Soltanmohammadzadeh; A Mortezazadeh; A Shaker; M Danehzan; A Zohouri; O Khosravi; R Nasimidoust; N Malekpour; E Kharazmi; M Babaei; M Nadirmohammadi; H Mashhadi-Abdollahi Journal: Vasc Health Risk Manag Date: 2011-07-11
Authors: Dele O Abegunde; Bakuti Shengelia; Anne Luyten; Alexandra Cameron; Francesca Celletti; Sania Nishtar; Vasu Pandurangi; Shanthi Mendis Journal: Bull World Health Organ Date: 2007-06 Impact factor: 9.408
Authors: Pietro A Modesti; Piergiuseppe Agostoni; Charles Agyemang; Sanjay Basu; Athanase Benetos; Francesco P Cappuccio; Antonio Ceriello; Stefano Del Prato; Robert Kalyesubula; Eoin O'Brien; Michael O Kilama; Stefano Perlini; Eugenio Picano; Gianpaolo Reboldi; Giuseppe Remuzzi; David Stuckler; Marc Twagirumukiza; Luc M Van Bortel; Ghassan Watfa; Dong Zhao; Gianfranco Parati Journal: J Hypertens Date: 2014-05 Impact factor: 4.844
Authors: Celestin Danwang; Mazou N Temgoua; Valirie Ndip Agbor; Aurel T Tankeu; Jean Jacques Noubiap Journal: BMJ Open Date: 2017-10-10 Impact factor: 2.692